Jilin Daojun Pharmaceutical Stock Co. Ltd.

Main purpose: Using pharmacokinetic parameters as the primary endpoint evaluation indicators, the pharmacokinetic behavior of the test preparation Cefuroxime Axetil Tablets provided by Jilin Daojun Pharmaceutical Co., Ltd. and the reference preparation Cefuroxime Axetil Tablets in healthy subjects after oral administration in the fasting/postprandial state was compared to evaluate the bioequivalence of the two preparations. Secondary purpose: Observe the safety of the test preparation Cefuroxime Axetil Tablets and the reference preparation Cefuroxime Axetil Tablets in healthy subjects.

Main objective: To compare the differences in absorption extent and rate between ibuprofen sustained-release capsules (0.3 g/capsule) provided by Jilin Daojun Pharmaceutical Co., Ltd. and ibuprofen sustained-release capsules (0.3 g/capsule, trade name: Fenbid®) produced by Sino-US Tianjin SmithKline Pharmaceutical Co., Ltd. in healthy adults under fasting and postprandial administration conditions, and to evaluate their bioequivalence.

To make a preliminary evaluation on the clinical efficacy and safety of Fuke Tengbai Granules in the treatment of chronic pelvic inflammatory disease (damp-heat and blood stasis syndrome).